The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Remission in Schizophrenia: Proposed Criteria and Rationale for Consensus
Abstract
New advances in the understanding of schizophrenia etiology, course, and treatment have increased interest on the part of patients, families, advocates, and professionals in the development of consensus-defined standards for clinical status and improvement, including illness remission and recovery. As demonstrated in the area of mood disorders, such standards provide greater clarity around treatment goals, as well as an improved framework for the design and comparison of investigational trials and the subsequent evaluation of the effectiveness of interventions. Unlike the approach to mood disorders, however, the novel application of the concept of standard outcome criteria to schizophrenia must reflect the wide heterogeneity of its long-term course and outcome, as well as the variable effects of different treatments on schizophrenia symptoms. As an initial step in developing operational criteria, an expert working group reviewed available definitions and assessment instruments to provide a conceptual framework for symptomatic, functional, and cognitive domains in schizophrenia as they relate to remission of illness. The first consensus-based operational criteria for symptomatic remission in schizophrenia are based on distinct thresholds for reaching and maintaining improvement, as opposed to change criteria, allowing for alignment with traditional concepts of remission in both psychiatric and nonpsychiatric illness. This innovative approach for standardizing the definition for outcome in schizophrenia will require further examination of its validity and utility, as well as future refinement, particularly in relation to psychosocial and cognitive function and dysfunction. These criteria should facilitate research and support a positive, longer-term approach to studying outcome in patients with schizophrenia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817 · cited 2×
“The development of the Hamilton Depression Rating Scale in 1960, its refinement over succeeding years, and its gradual incorporation as a standard measure in clinical trials provided clinical researchers with a consistent tool to assess change in symptoms over time (14).”
MethodResultThe Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
Negative Symptoms in Schizophrenia: Definition and Reliability
Andreasen, N. C. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290070020005 · Cited by 2,247
Self-citationNegative v Positive Schizophrenia: Definition and Validation
Andreasen, N. C. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290070025006 · Cited by 2,012
Self-citationFrank, E. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810330075011 · Cited by 1,959 · cited 5×
“In addition to developing definitions for these clinical concepts, this task force suggested methods through which their utility could be assessed, including reanalysis of existing data and prospective studies using outcomes guided by the new criteria (1).”
BackgroundMethodInfluentialThe Symptoms of Chronic Schizophrenia: A Re-examination of the Positive-Negative Dichotomy
Liddle, P. F. (1987) · British Journal of Psychiatry · doi:10.1192/bjp.151.2.145 · Cited by 1,427
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.4.1 · Cited by 1,348
Symptoms of Schizophrenia: Methods, Meanings, and Mechanisms
Andreasen, N. C. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950170015003 · Cited by 734
Self-citationLehman, A. F., Steinwachs, D. M., & The Survey Co-Investigators of the PORT Project (1998) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033303 · Cited by 598
Cited by
Schizophrenia: A Concise Overview of Incidence, Prevalence, and Mortality
McGrath, J., Saha, S., Chant, D., & Welham, J. (2008) · Epidemiologic Reviews · doi:10.1093/epirev/mxn001 · Cited by 2,280
Kahn, R. S., Sommer, I. E., Murray, R. M., Meyer-Lindenberg, A., Weinberger, D. R., Cannon, T. D., O'Donovan, M., Correll, C. U., Kane, J. M., van Os, J., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.67 · Cited by 1,124
Self-citationSchizophrenia, “just the facts” 4. Clinical features and conceptualization
Tandon, R., Nasrallah, H. A., & Keshavan, M. S. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.03.005 · Cited by 1,027
A Systematic Review and Meta-Analysis of Recovery in Schizophrenia
Jaaskelainen, E., Juola, P., Hirvonen, N., McGrath, J. J., Saha, S., Isohanni, M., Veijola, J., & Miettunen, J. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs130 · Cited by 907
Clinical implications of Brief Psychiatric Rating Scale scores
Leucht, S., Kane, J. M., Kissling, W., Hamann, J., Etschel, E., & Engel, R. (2005) · British Journal of Psychiatry · doi:10.1192/bjp.187.4.366 · Cited by 896
Self-citationGalletly, C., Castle, D., Dark, F., Humberstone, V., Jablensky, A., Killackey, E., Kulkarni, J., McGorry, P., Nielssen, O., & Tran, N. (2016) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867416641195 · Cited by 877
Definition and description of schizophrenia in the DSM-5
Tandon, R., Gaebel, W., Barch, D. M., Bustillo, J., Gur, R. E., Heckers, S., Malaspina, D., Owen, M. J., Schultz, S., Tsuang, M., et al. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.05.028 · Cited by 807
Self-citationPenttilä, M., Jääskeläinen, E., Hirvonen, N., Isohanni, M., & Miettunen, J. (2014) · British Journal of Psychiatry · doi:10.1192/bjp.bp.113.127753 · Cited by 716
The role of the cerebellum in schizophrenia
Andreasen, N. C., & Pierson, R. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.01.003 · Cited by 669
Self-citationBarnes, T. R., Drake, R., Paton, C., Cooper, S. J., Deakin, B., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I., et al. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 606
Davidson, L., & Roe, D. (2007) · Journal of Mental Health · doi:10.1080/09638230701482394 · Cited by 582
Improving outcomes of first‐episode psychosis: an overview
Fusar‐Poli, P., McGorry, P. D., & Kane, J. M. (2017) · World Psychiatry · doi:10.1002/wps.20446 · Cited by 575
Self-citationBellack, A. S. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj044 · Cited by 574
Wunderink, L., Nieboer, R. M., Wiersma, D., Sytema, S., & Nienhuis, F. J. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.19 · Cited by 567
Tohen, M., Frank, E., Bowden, C. L., Colom, F., Ghaemi, S. N., Yatham, L. N., Malhi, G. S., Calabrese, J. R., Nolen, W. A., Vieta, E., et al. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00726.x · Cited by 513
Khalsa, S. S., Portnoff, L. C., McCurdy-McKinnon, D., & Feusner, J. D. (2017) · Journal of Eating Disorders · doi:10.1186/s40337-017-0145-3 · Cited by 401
Schizophrenia, “Just the Facts” 5. Treatment and prevention Past, present, and future
Tandon, R., Nasrallah, H. A., & Keshavan, M. S. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.05.025 · Cited by 385
Andreasen, N. C., Nopoulos, P., Magnotta, V., Pierson, R., Ziebell, S., & Ho, B.-C. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.05.017 · Cited by 373
Self-citationRecovery From Schizophrenia: A Concept in Search of Research
Liberman, R. P., & Kopelowicz, A. (2005) · Psychiatric Services · doi:10.1176/appi.ps.56.6.735 · Cited by 370
Grant, P. M. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.129 · Cited by 353
Andreasen, N. C., Liu, D., Ziebell, S., Vora, A., & Ho, B.-C. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12050674 · Cited by 352
Self-citationDemjaha, A., Egerton, A., Murray, R. M., Kapur, S., Howes, O. D., Stone, J. M., & McGuire, P. K. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.06.011 · Cited by 342
Treatment-Resistant Schizophrenia
Elkis, H. (2007) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2007.04.001 · Cited by 338
Lally, J., Ajnakina, O., Stubbs, B., Cullinane, M., Murphy, K. C., Gaughran, F., & Murray, R. M. (2017) · British Journal of Psychiatry · doi:10.1192/bjp.bp.117.201475 · Cited by 335
The Myth of Schizophrenia as a Progressive Brain Disease
Zipursky, R. B., Reilly, T. J., & Murray, R. M. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs135 · Cited by 334
Schwarz, E., Maukonen, J., Hyytiäinen, T., Kieseppä, T., Orešič, M., Sabunciyan, S., Mantere, O., Saarela, M., Yolken, R., & Suvisaari, J. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2017.04.017 · Cited by 333
Cure therapeutics and strategic prevention: raising the bar for mental health research
Insel, T. R., & Scolnick, E. M. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001777 · Cited by 313
Long-Term Follow-Up of the TIPS Early Detection in Psychosis Study: Effects on 10-Year Outcome
Hegelstad, W. T. V., Larsen, T. K., Auestad, B., Evensen, J., Haahr, U., Joa, I., Johannesen, J. O., Langeveld, J., Melle, I., Opjordsmoen, S., et al. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11030459 · Cited by 309
Validity and utility of Hierarchical Taxonomy of Psychopathology (HiTOP): I. Psychosis superspectrum
Kotov, R., Jonas, K. G., Carpenter, W. T., Dretsch, M. N., Eaton, N. R., Forbes, M. K., Forbush, K. T., Hobbs, K., Reininghaus, U., Slade, T., et al. (2020) · World Psychiatry · doi:10.1002/wps.20730 · Cited by 309
Self-citationLally, J., Ajnakina, O., Di Forti, M., Trotta, A., Demjaha, A., Kolliakou, A., Mondelli, V., Reis Marques, T., Pariante, C., Dazzan, P., et al. (2016) · Psychological Medicine · doi:10.1017/s0033291716002014 · Cited by 298
The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal
Brissos, S., Veguilla, M. R., Taylor, D., & Balanzá-Martinez, V. (2014) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125314540297 · Cited by 297
Maintenance treatment with antipsychotic drugs for schizophrenia
Leucht, S., Tardy, M., Komossa, K., Heres, S., Kissling, W., & Davis, J. M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008016.pub2 · Cited by 290
Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors
Demjaha, A., Lappin, J. M., Stahl, D., Patel, M. X., MacCabe, J. H., Howes, O. D., Heslin, M., Reininghaus, U. A., Donoghue, K., Lomas, B., et al. (2017) · Psychological Medicine · doi:10.1017/s0033291717000435 · Cited by 289
Cortisol and Inflammatory Biomarkers Predict Poor Treatment Response in First Episode Psychosis
Mondelli, V., Ciufolini, S., Belvederi Murri, M., Bonaccorso, S., Di Forti, M., Giordano, A., Marques, T. R., Zunszain, P. A., Morgan, C., Murray, R. M., et al. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv028 · Cited by 286
Standardized remission criteria in schizophrenia
van Os, J., Burns, T., Cavallaro, R., Leucht, S., Peuskens, J., Helldin, L., Bernardo, M., Arango, C., Fleischhacker, W., Lachaux, B., et al. (2006) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2005.00659.x · Cited by 285
Self-citationAge at onset and the outcomes of schizophrenia: A systematic review and meta‐analysis
Immonen, J., Jääskeläinen, E., Korpela, H., & Miettunen, J. (2017) · Early Intervention in Psychiatry · doi:10.1111/eip.12412 · Cited by 280
Santesteban-Echarri, O., Paino, M., Rice, S., González-Blanch, C., McGorry, P., Gleeson, J., & Alvarez-Jimenez, M. (2017) · Clinical Psychology Review · doi:10.1016/j.cpr.2017.09.007 · Cited by 268
Cytokine Alterations in Schizophrenia: An Updated Review
Momtazmanesh, S., Zare-Shahabadi, A., & Rezaei, N. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00892 · Cited by 276
McGurk, S. R., Mueser, K. T., DeRosa, T. J., & Wolfe, R. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn182 · Cited by 272
Definitions and drivers of relapse in patients with schizophrenia: a systematic literature review
Olivares, J. M., Sermon, J., Hemels, M., & Schreiner, A. (2013) · Annals of General Psychiatry · doi:10.1186/1744-859x-12-32 · Cited by 270
“With correct management, many patients can achieve symptomatic remission [2] as defined, for example, by the Andreasen remission criteria [3].”
BackgroundNeurocognition: Clinical and Functional Outcomes in Schizophrenia
Lepage, M., Bodnar, M., & Bowie, C. R. (2014) · The Canadian Journal of Psychiatry · doi:10.1177/070674371405900103 · Cited by 266
Recovery from schizophrenia and the recovery model
Warner, R. (2009) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32832c920b · Cited by 264
Van Eck, R. M., Burger, T. J., Vellinga, A., Schirmbeck, F., & de Haan, L. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx088 · Cited by 260
Harvey, P. D., & Bellack, A. S. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn171 · Cited by 260
The acute efficacy of antipsychotics in schizophrenia: a review of recent meta-analyses
Haddad, P. M., & Correll, C. U. (2018) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125318781475 · Cited by 259
Clinical predictors of therapeutic response to antipsychotics in schizophrenia
Carbon, M., & Correll, C. U. (2014) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2014.16.4/mcarbon · Cited by 257
Do Patients with Schizophrenia Ever Show Periods of Recovery? A 15-Year Multi-Follow-up Study
Harrow, M. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi026 · Cited by 252
Howes, O. D., Whitehurst, T., Shatalina, E., Townsend, L., Onwordi, E. C., Mak, T. L. A., Arumuham, A., O’Brien, O., Lobo, M., Vano, L., et al. (2021) · World Psychiatry · doi:10.1002/wps.20822 · Cited by 243
Reappraising the long-term course and outcome of psychotic disorders: the AESOP-10 study
Morgan, C., Lappin, J., Heslin, M., Donoghue, K., Lomas, B., Reininghaus, U., Onyejiaka, A., Croudace, T., Jones, P. B., Murray, R. M., et al. (2014) · Psychological Medicine · doi:10.1017/s0033291714000282 · Cited by 248
Wunderink, L., Nienhuis, F. J., Sytema, S., Slooff, C. J., Knegtering, R., & Wiersma, D. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0502 · Cited by 234
Empirically Supported Treatment: Recommendations for a New Model
Tolin, D. F., McKay, D., Forman, E. M., Klonsky, E. D., & Thombs, B. D. (2015) · Clinical Psychology: Science and Practice · doi:10.1111/cpsp.12122 · Cited by 219
Few Preschool Boys and Girls with ADHD are Well-Adjusted During Adolescence
Lee, S. S., Lahey, B. B., Owens, E. B., & Hinshaw, S. P. (2008) · Journal of Abnormal Child Psychology · doi:10.1007/s10802-007-9184-6 · Cited by 204
Leonhardt, B. L., Huling, K., Hamm, J. A., Roe, D., Hasson-Ohayon, I., McLeod, H. J., & Lysaker, P. H. (2017) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2017.1378099 · Cited by 195
Recovery from schizophrenia: is it possible?
Vita, A., & Barlati, S. (2018) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000407 · Cited by 187
Determinants of treatment response in first-episode psychosis: an 18F-DOPA PET study
Jauhar, S., Veronese, M., Nour, M. M., Rogdaki, M., Hathway, P., Turkheimer, F. E., Stone, J., Egerton, A., McGuire, P., Kapur, S., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0042-4 · Cited by 183
“[34] remission criteria at 6 months to ascertain remission/ non-remission status.”
BackgroundMortality in Schizophrenia and Other Psychoses: A 10-Year Follow-up of the ӔSOP First-Episode Cohort
Reininghaus, U., Dutta, R., Dazzan, P., Doody, G. A., Fearon, P., Lappin, J., Heslin, M., Onyejiaka, A., Donoghue, K., Lomas, B., et al. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu138 · Cited by 156
Symptomatic and functional remission in patients with first-episode psychosis
Verma, S., Subramaniam, M., Abdin, E., Poon, L. Y., & Chong, S. A. (2012) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2012.01883.x · Cited by 149
Long-Term Diagnostic Stability and Outcome in Recent First-Episode Cohort Studies of Schizophrenia
Bromet, E. J. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi030 · Cited by 129
Treatment response after relapse in a placebo-controlled maintenance trial in schizophrenia
Emsley, R., Nuamah, I., Hough, D., & Gopal, S. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.02.030 · Cited by 110
“We also compared operationally defined remission rates (Andreasen et al., 2005) that require attaining a threshold score (≤3) on core PANSS items rather than reduction from baseline.”
BackgroundSivrioglu, E. Y., Kirli, S., Sipahioglu, D., Gursoy, B., & Sarandöl, E. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.07.004 · Cited by 102
Hypothalamic-pituitary-adrenal axis and clinical symptoms in first-episode psychosis
Belvederi Murri, M., Pariante, C. M., Dazzan, P., Hepgul, N., Papadopoulos, A. S., Zunszain, P., Di Forti, M., Murray, R. M., & Mondelli, V. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.08.013 · Cited by 93
Dopamine supersensitivity psychosis as a pivotal factor in treatment-resistant schizophrenia
Suzuki, T., Kanahara, N., Yamanaka, H., Takase, M., Kimura, H., Watanabe, H., & Iyo, M. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.02.021 · Cited by 81
Alvarez-Jimenez, M., O’Donoghue, B., Thompson, A., Gleeson, J. F., Bendall, S., Gonzalez-Blanch, C., Killackey, E., Wunderink, L., & McGorry, P. D. (2016) · CNS Drugs · doi:10.1007/s40263-016-0331-x · Cited by 80
Balcioglu, Y. H., & Kirlioglu, S. S. (2020) · Psychiatry Investigation · doi:10.30773/pi.2020.0185 · Cited by 80
Lysaker, P. H., Buck, K. D., Hammoud, K., Taylor, A. C., & Roe, D. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2005.12.844 · Cited by 74
Basavaraju, R., Ithal, D., Thanki, M. V., Ramalingaiah, A. H., Thirthalli, J., Reddy, R. P., Brady, R. O., Halko, M. A., Bolo, N. R., Keshavan, M. S., et al. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2021.10.005 · Cited by 70
Hansen, H. G., Starzer, M., Nilsson, S. F., Hjorthøj, C., Albert, N., & Nordentoft, M. (2023) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2022.5164 · Cited by 61
Long‐acting injectable antipsychotics in early psychosis: a literature review
Emsley, R., Chiliza, B., Asmal, L., Mashile, M., & Fusar‐Poli, P. (2013) · Early Intervention in Psychiatry · doi:10.1111/eip.12027 · Cited by 61
Grover, S., Singh, A., & Mattoo, S. (2016) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.192024 · Cited by 61
“,[20]), aged between 18 and 65 years, with illness of at”
BackgroundChien, W. T., Bressington, D., Yip, A., & Karatzias, T. (2017) · Psychological Medicine · doi:10.1017/s0033291717000526 · Cited by 57
Liang, S., Yu, W., Ma, X., Luo, S., Zhang, J., Sun, X., Luo, X., & Zhang, Y. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.01.052 · Cited by 55
Wang, L.-Q., Chien, W. T., Yip, L. K., & Karatzias, T. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s123239 · Cited by 54
Tse, S., Davidson, L., Chung, K.-F., Ng, K. L., & Yu, C. H. (2014) · Psychiatry: Interpersonal and Biological Processes · doi:10.1521/psyc.2014.77.1.41 · Cited by 53
Taylor, M., & Jauhar, S. (2019) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125319870033 · Cited by 51
Remission as perceived by people with schizophrenia, family members and psychiatrists
Karow, A., Naber, D., Lambert, M., & Moritz, S. (2012) · European Psychiatry · doi:10.1016/j.eurpsy.2011.01.013 · Cited by 51
Correll, C. U., Cucchiaro, J., Silva, R., Hsu, J., Pikalov, A., & Loebel, A. (2016) · CNS Spectrums · doi:10.1017/s1092852915000917 · Cited by 48
Revisiting the Diagnosis of Schizophrenia: Where have we been and Where are We Going?
Keller, W. R., Fischer, B. A., & Carpenter Jr., W. T. (2011) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00229.x · Cited by 46
Aboraya, A., & Nasrallah, H. A. (2016) · Annals of Clinical Psychiatry · doi:10.1177/104012371602800206 · Cited by 46
Drake, R. J., Nordentoft, M., Haddock, G., Arango, C., Fleischhacker, W. W., Glenthøj, B., Leboyer, M., Leucht, S., Leweke, M., McGuire, P., et al. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv015 · Cited by 42
Emsley, R., Asmal, L., Rubio, J. M., Correll, C. U., & Kane, J. M. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2019.11.025 · Cited by 41
Self-citationImpact of childhood adversities on the short-term course of illness in psychotic spectrum disorders
Schalinski, I., Fischer, Y., & Rockstroh, B. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.04.052 · Cited by 39
“months using stringent criteria proposed by Andreasen et al. (2005), the rate of”
Huhn, M., Leucht, C., Rothe, P., Dold, M., Heres, S., Bornschein, S., Schneider-Axmann, T., Hasan, A., & Leucht, S. (2021) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-020-01109-y · Cited by 38
Meesters, P. D., Comijs, H. C., de Haan, L., Smit, J. H., Eikelenboom, P., Beekman, A. T. F., & Stek, M. L. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2010.09.003 · Cited by 36
“Bankole et al. (2008) reported 49% of 198 patients (mean age 61 years) to be in remission (using the absence of psychiatric hospitalizations in the previous year as a substitute time criterion), while Leung et al.”
BackgroundInfluentialBraw, Y., Sitman, R., Sela, T., Erez, G., Bloch, Y., & Levkovitz, Y. (2012) · European Psychiatry · doi:10.1016/j.eurpsy.2011.02.002 · Cited by 36
“The study utilized recent criteria proposed for remission of depressive, manic and positive symptoms [35,5].”
BackgroundMethodToward Quality Care in ADHD: Defining the Goals of Treatment
Rostain, A., Jensen, P. S., Connor, D. F., Miesle, L. M., & Faraone, S. V. (2015) · Journal of Attention Disorders · doi:10.1177/1087054712473835 · Cited by 33
Achieving Remission as a Routine Goal of Pharmacotherapy in Attention-Deficit Hyperactivity Disorder
Ramos-Quiroga, J. A., & Casas, M. (2011) · CNS Drugs · doi:10.2165/11538450-000000000-00000 · Cited by 33
Tool-use Extends Peripersonal Space Boundaries in Schizophrenic Patients
Ferroni, F., Ardizzi, M., Magnani, F., Ferri, F., Langiulli, N., Rastelli, F., Lucarini, V., Giustozzi, F., Volpe, R., Marchesi, C., et al. (2022) · Schizophrenia Bulletin · doi:10.1093/schbul/sbac067 · Cited by 32
Quee, P. J., van der Meer, L., Krabbendam, L., de Haan, L., Cahn, W., Wiersma, D., van Beveren, N., Pijnenborg, G. H. M., Mulder, C. L., Bruggeman, R., et al. (2014) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12138 · Cited by 29
Pan, Y., Dempster, K., Jeon, P., Théberge, J., Khan, A. R., & Palaniyappan, L. (2021) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.200167 · Cited by 28
Landolt, K., Rössler, W., Ajdacic-Gross, V., Derks, E. M., Libiger, J., Kahn, R. S., & Fleischhacker, W. W. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.01.046 · Cited by 28
Negative symptoms, striatal dopamine and model-free reward decision-making in schizophrenia
Brandl, F., Knolle, F., Avram, M., Leucht, C., Yakushev, I., Priller, J., Leucht, S., Ziegler, S., Wunderlich, K., & Sorg, C. (2023) · Brain · doi:10.1093/brain/awac268 · Cited by 24
Predictors of disability: A 5-year cohort study of first-episode schizophrenia
Johnson, S., Sathyaseelan, M., Charles, H., & Jacob, K. S. (2014) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2014.01.003 · Cited by 24
Mindfulness meditation for Chinese patients with psychosis: A systematic review and meta-analysis
Tao, T. J., Hui, C. L. M., Lam, B. S. T., Ho, E. C. N., Hui, P. W. M., Suen, Y. N., Lin, J. J., Tong, A. C. Y., Lee, E. H. M., Chan, S. K. W., et al. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2021.08.033 · Cited by 21
Lemonde, A.-C., Joober, R., Malla, A., Iyer, S. N., Lepage, M., Boksa, P., & Shah, J. L. (2021) · The British Journal of Psychiatry · doi:10.1192/bjp.2020.157 · Cited by 20
Liu, C.-C., & Takeuchi, H. (2020) · CNS Drugs · doi:10.1007/s40263-019-00682-8 · Cited by 19
Disorganization at the stage of schizophrenia clinical outcome: clinical‐biological study
Nestsiarovich, A., Obyedkov, V., Kandratsenka, H., Siniauskaya, M., Goloenko, I., & Waszkiewicz, N. (2017) · European Psychiatry · doi:10.1016/j.eurpsy.2016.12.011 · Cited by 17
Antipsychotic maintenance treatment in schizophrenia and the importance of preventing relapse
Emsley, R. (2018) · World Psychiatry · doi:10.1002/wps.20521 · Cited by 16
Staring, A. B. P., van der Gaag, M., & Mulder, C. L. (2011) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0b013e3182174e97 · Cited by 16
“In this study, we used the recent remission criteria for schizophrenia (Andreasen et al., 2005) to test whether an integrating recovery style would predict remission at 1-year follow-up.”
BackgroundMethodInfluentialPartnerships for Meaningful Community Living: Rehabilitation and Recovery‐Informed Practices
Killackey, E., Harvey, C., Amering, M., & Herrman, H. (2015) · Psychiatry · doi:10.1002/9781118753378.ch97 · Cited by 14
Grover, S., Sahoo, S., Nehra, R., Chakrabarti, S., & Avasthi, A. (2017) · International Journal of Social Psychiatry · doi:10.1177/0020764017691314 · Cited by 14
Metadata
- Authors
- Andreasen, N. C., Carpenter, W. T., Kane, J. M., Lasser, R. A., Marder, S. R., & Weinberger, D. R.
- Venue
- American Journal of Psychiatry
- Published
- 2005-03-01
- Volume
- 162
- Issue
- 3
- Pages
- 441-449
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2135689380
- Cited by
- 2,343
- References
- 52
- FWCI
- 41.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.